FDA Approves Abbott's New Spinal Cord Stimulation Device; Provides Tailored Relief to Multiple Pain Areas and Adds More Treatment Options for Evolving Pain Conditions Pharmaceutical Investing
Applied UV Files Trademark Infringement Lawsuit Against Aeroclean Technologies Medical Device Investing
Knight Therapeutics Assumes Commercial Activities and Re-Launches Exelon in Brazil Pharmaceutical Investing
Johnson & Johnson Ends Global Sales of Cancer-Causing Baby Powder Amid Increased Scrutiny from Consumer Litigation, Science Pharmaceutical Investing
New Study Shows Abbott's Blood Test for Concussion Could Predict Outcomes from Brain Injury and Inform Treatment Interventions Pharmaceutical Investing
